<DOC>
<DOCNO>EP-0610246</DOCNO> 
<TEXT>
<INVENTION-TITLE>
NOVEL THROMBIN-INHIBITING PROTEIN FROM TICKS
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3855	C07K14435	C07K1481	C12P2102	A61K3556	A61P702	A61K3800	A61K3564	A61K3800	C07K100	C07K114	C12N1509	A61P700	C12N1515	C07K14435	C07K1481	C12P2102	C12N1509	C12N1515	A61K3855	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	C07K	C07K	C12P	A61K	A61P	A61K	A61K	A61K	C07K	C07K	C12N	A61P	C12N	C07K	C07K	C12P	C12N	C12N	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	C07K14	C07K14	C12P21	A61K35	A61P7	A61K38	A61K35	A61K38	C07K1	C07K1	C12N15	A61P7	C12N15	C07K14	C07K14	C12P21	C12N15	C12N15	A61K38	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
BASF AG
</APPLICANT-NAME>
<APPLICANT-NAME>
BASF AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BIALOJAN SIEGFRIED
</INVENTOR-NAME>
<INVENTOR-NAME>
FRIEDRICH THOMAS
</INVENTOR-NAME>
<INVENTOR-NAME>
KOERWER WOLFGANG
</INVENTOR-NAME>
<INVENTOR-NAME>
KROEGER BURKHARD
</INVENTOR-NAME>
<INVENTOR-NAME>
BIALOJAN, SIEGFRIED
</INVENTOR-NAME>
<INVENTOR-NAME>
FRIEDRICH, THOMAS
</INVENTOR-NAME>
<INVENTOR-NAME>
KOERWER, WOLFGANG
</INVENTOR-NAME>
<INVENTOR-NAME>
KROEGER, BURKHARD
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A protein with a thrombin-inhibitory effect from 
ticks of the genus Ornithodoros, which has an isoelectric 

point at pH 4-5, a molecular weight of 25700 ± 3000 
dalton determined by SDS polyacrylamide gel electrophoresis 

by the Lämmli method, and the partial amino-acid 
sequences Val-Ala-Lys-Phe-Ala-X-Asn-Ser-Gly-Ser-Gl
u-Thr- 
Gly, His-Ala-Y-Phe-Glu, Arg-Val-Ser-Asp-Phe-Glu and Phe-Val-Tyr-Thr-Ile-Glu, 

where X and Y can be identical or 
different and each is a naturally occurring amino acide. 
A DNA sequence which codes for a protein as 
claimed in claim 1. 
An expression vector which contains a DNA 
sequence as claimed in claim 2. 
The use of a protein as claimed in claim 1 for 
producing a drug for inhibiting blood coagulation. 
</CLAIMS>
</TEXT>
</DOC>
